MARINOMED BIOTECH AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.7 EUR | -1.47% |
|
-2.34% | -42.81% |
| 04-16 | Transcript : Marinomed Biotech AG, 2023 Earnings Call, Apr 16, 2024 | |
| 04-16 | Marinomed Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 27.96M | - | - | ||||
| 91.42B | ||||||
| 41.08B | ||||||
| 34.26B | ||||||
| 25.27B | ||||||
| 15.27B |
